Orchard Capital Management’s Intellia Therapeutics NTLA Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$1.05M	Hold	82,030	–	–	1.38%	29
2025 Q4	$737K	Buy	82,030 +432	+0.5%	+$5.95K	0.64%	29
2025 Q3	$1.41M	Buy	81,598 +2,390	+3%	+$29.4K	1.86%	26
2025 Q2	$743K	Sell	79,208 -106,288	-57%	-$873K	0.82%	29
2025 Q1	$1.32M	Buy	185,496 +173,339	+1,426%	+$1.75M	0.9%	28
2024 Q4	$142K	Buy	12,157 +171	+1%	+$2.67K	0.06%	54
2024 Q3	$246K	Sell	11,986 -158,020	-93%	-$3.64M	0.08%	51
2024 Q2	$3.8M	Sell	170,006 -2,310	-1%	-$55K	1.15%	32
2024 Q1	$4.74M	Buy	172,316 +2,310	+1%	+$64.2K	1.39%	33
2023 Q4	$5.18M	Buy	170,006 +10,851	+7%	+$312K	1.62%	32
2023 Q3	$5.03M	Hold	159,155	–	–	1.86%	31
2023 Q2	$6.49M	Buy	+159,155	New	+$6.45M	2.18%	28